A comprehensive conversation about the state of pulmonary embolism care today, including keys to a strong program, use of ...

According to the study, the PEACE Score accurately stratifies pulmonary embolism risk, with strong links to echo ...

In the fight against Alzheimer's, Lion's mane mushroom shows promise. A recent study reveals that its extract can ease ...

Sodium nitroprusside improves circulatory failure in rabbit acute pulmonary embolism combined with shock model possibly by enhancing NO release and inhibiting TLR4/NF-кB/HIF-1α signaling pathway ...

E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism ...

According to Nova One Advisor, the global pulmonary embolism market size is calculated at USD 2.15 billion in 2024, grows to USD 2.33 billion in 2025, and is projected to hit around USD 4.78 billion ...

Michael Matthews ruled out of Tour de France and sidelined as team discover 'signs of a pulmonary embolism' at altitude camp By James Moultrie published 13 June 2025 ...

SAN FRANCISCO — Pulmonary embolisms are more common among children than previous literature has indicated, according to an abstract presented at the American Thoracic Society International ...

Protective effects of Ejiao on chronic obstructive pulmonary disease in mice via modulation of the ER/AKT/NF-κB pathway ...

Pulmonary embolism in children has been acknowledged to be an issue in clinical care but was thought to be rare. Now new research published at the ATS 2025 International Conference shows that it ...

Nerandomilast has been shown to slow the progression of idiopathic pulmonary fibrosis, but an assessment of its effects in other types of progressive pulmonary fibrosis is needed.

The AVENTUS Trial successfully met its primary endpoints, demonstrating both safety and efficacy in the treatment of acute intermediate-risk pulmonary embolism (PE) patients.